PiCHEM
Desconocido
BETACURE: Personalized diagnosis and treatment of hyperinsulinemic hypoglycaemia caused by beta cell pathology
PICHEM FORSCHUNGSUND ENTWICKLUNGSGMBH
participó en un
FP7:
Background:
Hyperinsulinaemic hypoglycaemia (HH) is a potentially lethal disease caused by over functioning beta cells derived from the panc...
Financiado
Financiado
Myasterix: Clinical safety immunogenicity and efficacy of a therapeutic vaccine that combines peptides mimicki...
PICHEM FORSCHUNGSUND ENTWICKLUNGSGMBH
participó en un
FP7:
The MYASTERIX project will advance a therapeutic vaccine candidate (designated orphan drug) indicated for the autoimmune disease myasthenia...
Financiado
Financiado
* No se disponen de datos de la empresa actual.